Patents by Inventor JENNY HSU

JENNY HSU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Magnetic lid and assembly
    Patent number: 10813433
    Abstract: A jar and lid assembly that includes a jar assembly configured to hold a product. The jar and lid assembly also includes a lid assembly coupled to the jar assembly and includes an outer lid portion and an inner lid portion. The coupling of the lid assembly may be by rotation to secure the lid assembly using threads. A magnet may be positioned within the lid assembly to magnetically couple a cosmetic implement to an outer surface of the lid assembly.
    Type: Grant
    Filed: March 10, 2017
    Date of Patent: October 27, 2020
    Assignee: HCT GROUP HOLDINGS LIMITED
    Inventors: Timothy Thorpe, Adrian Apodaca, Stephen Burditt, Stephen Chen, Jenny Hsu
  • MAGNETIC LID AND ASSEMBLY
    Publication number: 20170265625
    Abstract: A jar and lid assembly that includes a jar assembly configured to hold a product. The jar and lid assembly also includes a lid assembly coupled to the jar assembly and includes an outer lid portion and an inner lid portion. The coupling of the lid assembly may be by rotation to secure the lid assembly using threads. A magnet may be positioned within the lid assembly to magnetically couple a cosmetic implement to an outer surface of the lid assembly.
    Type: Application
    Filed: March 10, 2017
    Publication date: September 21, 2017
    Inventors: TIMOTHY THORPE, ADRIAN APODACA, STEPHEN BURDITT, STEPHEN CHEN, JENNY HSU
  • Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase
    Publication number: 20040014774
    Abstract: This invention relates to the modulation and/or inhibition of cell signaling, cell proliferation, cell inflammatory response, the control of abnormal cell growth and cell reproduction. More specifically, this invention relates to the use of mono- and/or bicyclic aryl or heteroaryl quinazoline compounds in inhibiting cell proliferation, including compounds which are useful protein tyrosine kinase (PTK) inhibitors. The method of treating cell proliferation and/or differentiation or mediator release using said quinazoline compounds and their use in pharmaceutical compositions is described.
    Type: Application
    Filed: July 10, 2003
    Publication date: January 22, 2004
    Inventors: Michael R. Myers, Alfred P. Spada, Martin P. Maguire, Paul E. Persons, Asher Zilberstein, Chin-Yi Jenny Hsu, Susan E. Johnson
  • Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase
    Patent number: 6645969
    Abstract: This invention relates to the modulation and/or inhibition of cell signaling, cell proliferation, cell inflammatory response, the control of abnormal cell growth and cell reproduction. More specifically, this invention relates to the use of mono- and/or bicyclic aryl or heteroaryl quinazoline compounds in inhibiting cell proliferation, including compounds which are useful protein tyrosine kinase (PTK) inhibitors. The method of treating cell proliferation and/or differentiation or mediator release using said quinazoline compounds and their use in pharmaceutical compositions is described.
    Type: Grant
    Filed: May 18, 1995
    Date of Patent: November 11, 2003
    Assignee: Aventis Pharmaceuticals Inc.
    Inventors: Michael R. Myers, Alfred P. Spada, Martin P. Maguire, Paul E. Persons, Asher Zilberstein, Chin-Yi Jenny Hsu, Susan E. Johnson
  • Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase
    Patent number: 5714493
    Abstract: This invention relates to the treatment of intimation in a patient suffering from such disorder. More specifically, the invention relates to mono- and/or bicyclic aryl or heteroaryl quinazoline compounds in the treatment of inflammation.
    Type: Grant
    Filed: June 4, 1996
    Date of Patent: February 3, 1998
    Assignee: Rhone-Poulenc Rorer Pharmaceuticals, Inc.
    Inventors: Michael R. Myers, Alfred P. Spada, Martin P. Maguire, Paul E. Persons, Asher Zilberstein, Chin-Yi Jenny Hsu, Susan E. Johnson
  • Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase
    Patent number: RE37650
    Abstract: This invention relates to the treatment of intimation in a patient suffering from such disorder. More specifically, the invention relates to mono- and/or bicyclic aryl or heteroaryl quinazoline compounds in the treatment of inflammation.
    Type: Grant
    Filed: February 2, 2000
    Date of Patent: April 9, 2002
    Assignee: Aventis Pharmacetical Products, Inc.
    Inventors: Michael R. Myers, Alfred P. Spada, Martin P. Maguire, Paul E. Persons, Asher Zilberstein, Chin-Yi Jenny Hsu, Susan E. Johnson
  • Spatula cosmetic applicator
    Patent number: D841235
    Type: Grant
    Filed: March 15, 2017
    Date of Patent: February 19, 2019
    Assignee: HCT GROUP HOLDINGS LIMITED
    Inventors: Timothy Thorpe, Adrian Apodaca, Stephen Burditt, Stephen Chen, Jenny Hsu